A new study shows that a low-dose injection of eskatamine given after childbirth reduces major depressive episodes in those with depression during pregnancy by about 75% at 42 days postpartum.  Low-dose ketamine or esketamine has previously been shown to reduce depression in mothers having a cesarean delivery but had excluded mothers with depression during pregnancy from the study.